Granulocyte-Macrophage Colony-Stimulating Factor Inhibition Ameliorates Innate Immune Cell Activation, Inflammation, and Salt-Sensitive Hypertension
Cells · 2025
DOI: 10.3390/cells14151144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Hannah L Smith und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX 77807, USA. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Hypertension, Inflammation, Immunity, Innate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Hypertension (HTN) is a major contributor to global morbidity and manifests in several variants, including salt-sensitive hypertension (SSHTN). SSHTN is defined by an increase in blood pressure (BP) in response to high dietary salt, and is associated with heightened cardiovascular risk, renal damage, and immune system activation. However, the role of granulocyte-macrophage colony-stimulating factor (GM-CSF) has not yet been explored in the context of SSHTN. Previously, we reported that GM-CSF is critical in priming bone marrow-derived (BMD)-macrophages (BMD-Macs) and BMD-dendritic cells (BMD-DCs) to become activated (CD38+) in response to salt. Further exploration revealed these cells differentiated into BMD-M1 Macs, CD38+ BMD-M1 Macs, BMD-type-2 conventional DCs (cDC2s), and CD38+ BMD-cDC2s. Additionally, BMD-monocytes (BMDMs) grown with GM-CSF and injected into SSHTN mice traffic to the kidneys and differentiate into Macs, CD38+ Macs, DCs, and CD38+ DCs. In the current study, we treated SSHTN mice with an anti-GM-CSF antibody (aGM) and found that preventive aGM treatment mitigated BP, prevented renal inflammation, and altered renal immune cells. In mice with established SSHTN, aGM treatment attenuated BP, reduced renal inflammation, and differentially affected renal immune cells. Adoptive transfer of aGM-treated BMDMs into SSHTN mice resulted in decreased renal trafficking. Additionally, aGM treatment of BMD-Macs, CD38+ BMD-M1 Macs, BMD-DCs, and CD38+ BMD-cDC2s led to decreased pro-inflammatory gene expression. These findings suggest that GM-CSF plays a role in SSHTN and may serve as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX 77807, USA.
ORCID-Profile: Hannah L Smith, Bethany L Goodlett, Ava R Gostomski, Brett M Mitchell
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Smith, H. L., Goodlett, B. L., Peterson, G. C., Zamora, E. N., Gostomski, A. R., & Mitchell, B. M. (2025). Granulocyte-Macrophage Colony-Stimulating Factor Inhibition Ameliorates Innate Immune Cell Activation, Inflammation, and Salt-Sensitive Hypertension. Cells. https://doi.org/10.3390/cells14151144
Vancouver
Smith HL, Goodlett BL, Peterson GC, Zamora EN, Gostomski AR, Mitchell BM. Granulocyte-Macrophage Colony-Stimulating Factor Inhibition Ameliorates Innate Immune Cell Activation, Inflammation, and Salt-Sensitive Hypertension. Cells. 2025. doi:10.3390/cells14151144
BibTeX
@article{Smith2025,
author = {Smith, Hannah L and Goodlett, Bethany L and Peterson, Gabriella C and Zamora, Emily N and Gostomski, Ava R and Mitchell, Brett M},
title = {Granulocyte-Macrophage Colony-Stimulating Factor Inhibition Ameliorates Innate Immune Cell Activation, Inflammation, and Salt-Sensitive Hypertension},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14151144}
}
EUVIMED